Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Emmanuel Oger, Benjamin Lefèvre et al.|EClinicalMedicine|2023Cited by 16
Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patientsHortense Thomas, Sophie Julia, Tom Alix et al.|Journal of Medical Genetics|2024Cited by 7
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory DomainsMedha Barbhaiya, Thomas Dörner, Guilherme Ramires de Jesús et al.|Current Rheumatology Reports|2025Cited by 0